This free article provides a good summary of further disease targets for a brain penetrant PI3K/mTOR inhibitor like paxalisib (see last point of tinhat‘s post above):
https://dx.doi.org/10.3390%2Fijms20225792
- Forums
- ASX - By Stock
- Ann: Kazia releases final data from P2 paxalisib trial
This free article provides a good summary of further disease...
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online